GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGS

GeneDx Holdings Corp. (NasdaqGS: WGS) is the subject of a securities class action lawsuit. Investors who purchased or acquired shares between April 16, 2025, and May 4, 2026, with losses over $100,000, must file lead plaintiff applications by August 3, 2026. The suit claims GeneDx and its executives failed to disclose material information during the Class Period. On May 4, 2026, GeneDx reported a drop in adjusted gross margin from 74% to 69%, missed revenue estimates for its exome and genome lines, and lowered its full-year revenue guidance. The company also disclosed a $31.2 million impairment loss related to its acquisition of Fabric Genomics. Following this news, GeneDx shares fell by 49.2%.